Qyuns Therapeutics Co., Ltd.

SEHK:2509 Stock Report

Market Cap: HK$2.0b

Qyuns Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2509?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme15,550,0007%
Institutions30,077,20013.5%
Public Companies35,900,00016.2%
Private Companies63,750,00028.7%
General Public76,794,40034.6%

Dilution of Shares: 2509 only recently listed within the past 12 months


Top Shareholders

Top 9 shareholders own 65.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18%
Hangzhou Quanyi Investment Management Partnership (General Partnership)
40,000,000HK$357.2m0%no data
16.2%
Huadong Medicine Co., Ltd
35,900,000HK$320.6m0%no data
8.44%
Taizhou Hongtai Health Investment Management Center (Limited Partnership)
18,750,000HK$167.4m0%no data
7%
Qyuns Therapeutics Co., Ltd., ESOP
15,550,000HK$138.9m0%no data
4.92%
Jingwei Venture Capital (Beijing) Investment Management Consulting Co., Ltd.
10,920,000HK$97.5m0%6.91%
4.36%
Taizhou Huaxin Venture Capital Management Co., Ltd.
9,680,400HK$86.4m0%no data
3.38%
Taizhou Rongjianda Angel Venture Capital Investment Co., Ltd.
7,500,000HK$67.0m0%no data
2.25%
Shanghai Quanyou Fanyue Investment Management Partnership (Limited Partnership)
5,000,000HK$44.7m0%no data
0.89%
Huadong Medicine Investment Holding (Hong Kong)
1,976,800HK$17.7m0%no data